Patent Applications
This article was originally published in SRA
Executive Summary
Update on electronic filing of European and international patents
You may also be interested in...
US High Court Punts On ‘Objective Falsity’ FCA Standard
Can a false-claims suit be filed if doctors have different opinions about whether a treatment was necessary? The Supreme Court won’t say.
EU Launches ‘Structured Dialog’ To Thrash Out Supply Chain Concerns
The pharmaceutical industry and other stakeholders have taken part in the launch event for a new initiative intended to tackle issues that have been amplified by the COVID-19 pandemic, such as supply chain resilience and medicine shortages. The project has drawn a mixed response from industry bodies.
Samsung Bioepis Pushes Stelara Rival Into Phase I
Samsung Bioepis has announced that its SB17 proposed biosimilar ustekinumab rival to Janssen’s $7.7bn Stelara brand has moved into Phase I trials.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: